PTC Therapeutics, Inc. (PTCT)

PTC Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	2,503	2,080	2,744	2,816	4,164	2,960
Market Cap Growth	-37.67%	-24.20%	-2.56%	-32.38%	40.68%	70.95%
Enterprise Value	2,039	1,618	3,037	2,578	3,481	2,602
PE Ratio	-	-3.32	-4.91	-5.37	-9.50	-11.77
PS Ratio	2.70	2.22	3.93	5.23	10.94	9.64
PB Ratio	-2.49	-2.54	-7.90	1958.20	8.64	4.98
P/FCF Ratio	-25.94	-11.13	-7.06	-10.07	-19.65	-26.34
P/OCF Ratio	-38.31	-13.13	-7.69	-11.20	-21.46	-30.01
EV/Sales Ratio	2.20	1.73	4.35	4.79	9.14	8.47
EV/EBITDA Ratio	-7.20	-5.05	-8.48	-7.14	-13.62	-13.58
EV/EBIT Ratio	-3.51	-2.85	-6.11	-5.96	-10.04	-11.44
EV/FCF Ratio	-20.54	-8.66	-7.81	-9.22	-16.43	-23.15
Debt / Equity Ratio	-0.47	-0.51	-2.03	372.31	0.87	0.55
Debt / EBITDA Ratio	-1.72	-1.29	-1.97	-1.48	-1.64	-1.71
Debt / FCF Ratio	-4.90	-2.22	-1.81	-1.92	-1.98	-2.92
Quick Ratio	1.88	1.72	1.39	1.74	4.23	3.15
Current Ratio	2.03	2.02	1.71	1.87	4.44	3.30
Asset Turnover	0.59	0.62	0.41	0.27	0.21	0.21
Interest Coverage	-3.53	-4.39	-5.47	-5.03	-6.15	-18.21
Return on Equity (ROE)	78.20%	99.20%	264.10%	-351.90%	-83.70%	-44.50%
Return on Assets (ROA)	-36.90%	-41.10%	-32.50%	-25.80%	-23.60%	-17.20%
Return on Capital (ROIC)	105.31%	140.56%	-132.75%	-69.85%	-45.27%	-20.90%
Earnings Yield	-23.14%	-30.13%	-20.37%	-18.61%	-10.52%	-8.50%
FCF Yield	-3.43%	-8.98%	-14.17%	-9.93%	-5.09%	-3.80%
Buyback Yield / Dilution	-3.75%	-4.34%	-1.79%	-6.72%	-12.17%	-26.38%
Total Shareholder Return	-3.75%	-4.34%	-1.79%	-6.72%	-12.17%	-26.38%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).